Needle-Free injection systems were being used to immunize large numbers of individuals after WWII. Did these needle-free systems, called ‘Jet Injectors’ actually work? If so, why has it taken us so long to develop a needle-free injection system that is a viable drug delivery tool today? Join host Dr. Larry Kaskel interviewing Charles Potter, CEO of Glide Pharmaceuticals, about the Glide Solid Dose Injector, a WSJ innovation runner up in 2007.
Needle-Free injection systems were being used to immunize large numbers of individuals after WWII. Did these needle-free systems, called ‘Jet Injectors’ actually work? If so, why has it taken us so long to develop a needle-free injection system that is a viable drug delivery tool today? Join host Dr. Larry Kaskel interviewing Charles Potter, CEO of Glide Pharmaceuticals, about the Glide Solid Dose Injector, a WSJ innovation runner up in 2007.
